ONCY - Oncolytics Biotech, Inc.
Previous close
0.9527
0 0%
Share volume: 171,313
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.95
0.00
0.00%
Summary score
44%
Profitability
50%
Dept financing
16%
Liquidity
37%
Performance
46%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1203.84%
Return on assets
-27.33%
Return on sales
0%
Return on invested capital
134.27%
Total debt ratio
50.58%
Debt ratio change over timeo
-0.58%
Current Ratio
4.13%
Quick Ratio
0%
Cash Position Ratio
2.88%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
4335.03%
Return on assets
-29.26%
Return on sales
0%
Return on invested capital
138.95%
Total debt ratio
79.99%
Debt ratio change over timeo
-0.43%
Current Ratio
2.96%
Quick Ratio
0%
Cash Position Ratio
0.95%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
17665.17%
Return on assets
-34.13%
Return on sales
0%
Return on invested capital
156.98%
Total debt ratio
100.55%
Debt ratio change over time
-0.08%
Current Ratio
1.47%
Quick Ratio
0%
Cash Position Ratio
0.08%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
1097.03%
Return on assets
-122.06%
Return on sales
0%
Return on invested capital
4.92%
Total debt ratio
-58.12%
Debt ratio change over time
-0.58%
Current Ratio
2.08%
Quick Ratio
0%
Cash Position Ratio
1.08%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ONCY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1203.84% | 3.38% | 10.1% | 6.09% |
| Return on assets | -27.33% | 3.79% | 3.51% | 5.38% |
| Return on sales | 0% | 33.46% | 42.92% | 33.01% |
| Return on invested capital | 134.27% | 4.88% | 8.3% | 11.96% |
| Profitability | 50% | 38% | 43% | 47% |
| Total debt ratio | 50.58% | 100.22% | 71.21% | 29.5% |
| Debt ratio change over time | -0.58% | 14.95% | 5.12% | 1.7% |
| Dept financing | 13% | 50% | 26% | 10% |
| Current Ratio | 2.96% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 0.95% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 24% | 53% | 55% |
| Short-term ratios | ONCY | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 4335.03% | -24.18% | 18.55% | 5.09% |
| Return on assets | -29.26% | 4.92% | 3.95% | 4% |
| Return on sales | 0% | 37.6% | 41.32% | 27.89% |
| Return on invested capital | 138.95% | 7.93% | 10.38% | 10.86% |
| Profitability | 50% | 49% | 47% | 39% |
| Total debt ratio | 79.99% | 112.95% | 82.58% | 25.55% |
| Debt ratio change over time | -0.43% | 16.62% | 5.88% | 2.04% |
| Dept financing | 18% | 50% | 27% | 9% |
| Current Ratio | 2.96% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 0.95% | 0.97% | 0.66% | 1.72% |
| Liquididy | 32% | 35% | 42% | 75% |